Japan is on the verge of a medical revolution, focusing on regenerative medicine using stem cells. Following the award-winning work of Shinya Yamanaka, researchers are developing various therapies aimed at treating conditions like blindness, heart disease, and neurodegeneration. The country has invested heavily in this field, leading to promising early clinical trials. Major strides include the crafting of specialized cells and the establishment of advanced facilities for patient treatment, signaling that Japan is ready to bring these innovative therapies to the market.
"After nearly two decades of hard work and setbacks, many say that Japan is on the cusp of bringing these therapies to market."
"There was so much hype; people thought, 'Now we can treat any incurable disease'," says Shigeto Shimmura.
"Regenerative medicine in Japan is moving very dramatically," says Masayo Takahashi.
"The Japanese government has poured more than ¥110 billion (US$760 million today) into research and development on regenerative medicine."
Collection
[
|
...
]